Central Bank & Trust Co. Has $7.80 Million Stake in Lam Research Corporation $LRCX

Key Points

• Central Bank & Trust Co. reduced its stake in Lam Research by 5.0%, holding 80,106 shares valued at approximately $7.80 million, making Lam Research the firm's 24th largest position.
• Vanguard Group significantly increased its stake in Lam Research by 6.9%, while UBS AM raised its stake by an impressive 6,383.5% during the past quarters.
• Lam Research recently declared an increased quarterly dividend of $0.26 per share, yielding 0.9%, up from its previous dividend of $0.23.

Central Bank & Trust Co. decreased its stake in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 5.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 80,106 shares of the semiconductor company's stock after selling 4,178 shares during the quarter. Lam Research accounts for about 1.3% of Central Bank & Trust Co.'s portfolio, making the stock its 24th largest position. Central Bank & Trust Co.'s holdings in Lam Research were worth $7,798,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its stake in Lam Research by 6.9% in the first quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company's stock valued at $9,389,358,000 after buying an additional 8,364,375 shares during the period. Invesco Ltd. lifted its stake in Lam Research by 2.8% in the first quarter. Invesco Ltd. now owns 17,330,771 shares of the semiconductor company's stock valued at $1,259,947,000 after buying an additional 472,636 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Lam Research by 6,383.5% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,574,691 shares of the semiconductor company's stock valued at $980,500,000 after buying an additional 13,365,317 shares during the period. Goldman Sachs Group Inc. lifted its stake in Lam Research by 25.8% in the first quarter. Goldman Sachs Group Inc. now owns 9,536,708 shares of the semiconductor company's stock valued at $693,319,000 after buying an additional 1,953,221 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its stake in Lam Research by 4.9% in the first quarter. Charles Schwab Investment Management Inc. now owns 8,900,506 shares of the semiconductor company's stock valued at $647,067,000 after buying an additional 418,077 shares during the period. Institutional investors and hedge funds own 84.61% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on LRCX shares. Cantor Fitzgerald raised their price target on Lam Research from $115.00 to $120.00 and gave the stock an "overweight" rating in a research report on Thursday, August 21st. TD Cowen increased their price objective on Lam Research from $100.00 to $125.00 and gave the stock a "buy" rating in a report on Thursday, July 31st. The Goldman Sachs Group began coverage on Lam Research in a research note on Thursday, July 10th. They issued a "buy" rating and a $115.00 price target for the company. Needham & Company LLC raised their price target on Lam Research from $110.00 to $115.00 and gave the company a "buy" rating in a research note on Thursday, July 31st. Finally, Oppenheimer raised their price target on Lam Research from $110.00 to $120.00 and gave the company an "outperform" rating in a research note on Thursday, July 31st. Twenty investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Lam Research presently has an average rating of "Moderate Buy" and a consensus price target of $107.96.

Lam Research Stock Performance

LRCX opened at $119.21 on Tuesday. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $119.33. The stock has a market cap of $150.87 billion, a price-to-earnings ratio of 28.66, a PEG ratio of 1.50 and a beta of 1.76. The business has a 50 day moving average of $101.49 and a 200-day moving average of $87.10. The company has a quick ratio of 1.55, a current ratio of 2.21 and a debt-to-equity ratio of 0.38.

Lam Research (NASDAQ:LRCX - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.21 by $0.12. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The company had revenue of $5.17 billion during the quarter, compared to analysts' expectations of $4.99 billion. During the same period last year, the firm posted $1.03 earnings per share. The business's revenue was up 33.6% on a year-over-year basis. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. On average, equities research analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th will be issued a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Wednesday, September 24th. This is an increase from Lam Research's previous quarterly dividend of $0.23. Lam Research's payout ratio is 22.12%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.